1Jaffe ES,Harris NL,Stein H,et al.Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues.Lyon.France:IARC Press,2001.35-38.
2Thiele J,Kvasinicka H M,Zankocich R,et al.Clinical and morphologyical criteria for the diagnosis of prefibrotic idiopathic(primary)myelofibrosis.Ann Hematol,2001,80:160.
5Gangat N,Wolanskyj A P,McClure R F,et al.Risk stratification for survival and leukemic transformation in essential thrombocythemia:a single institutional study of 605 patients[J].Leukemia,2007,21(2):270-276.
6Daniella M B,Kerbauy,Theodore A Gooley,et al.Hematopoietic cell transplantation as curative therapy for idiopathic myelofibrosis,advanced polycythemia vera,and essential thrombocythemia[J].Biology of Blood and Marrow Transplantation,2007,13:355-365.
7Li Z H,Gooley T,Appelbaum F R,et al.Splenectomy and hemopoietic stem cell transplantation for myelofibrosis[J].Blood,2001,97(7):2180-2181.
8Hsu H C,Tan L Y,Au L C,et al.Detection of bcr-abl gene expre-ssion at a low level in blood ceels of some patients with essential thrombocythemia[J].Lab Clin Med,2004,143(2):125-129.
9Hussein K,Bock O,Theophile K,et al.Chronic myeloproliferative diseases with concurrent BCR-ABL junction and JAK2V617F mutation[J].Leukemia,2008,22:1059-1062.
10Jaffe E S, Harris N L, Stein H, et al. Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues [ M ]. Lyon : IARC Press, 2001: 35- 38.
